Humboldt — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Synvitrobio, Inc.synvitrobio.comSep 2023SEC filingmedium confidence

Revr (SynVitro Bio) designs functional proteins by combining AI models with large-scale biophysical data generated from an automated wet lab platform, using a closed-loop process to speed up protein refinement.

AI & Machine LearningBiotechDeep TechHealthtechSan Leandro, US

Zachary Sun(Executive Officer, Director)Michael Nemzek(Executive Officer, Director)Corinna Chen(CEO)

Board seatFrancisco Dopazo· per SEC Form D · $17.6M raise · filed Sep 2023

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.